DGAP-News: MediClin AG: Increase in sales and improvement

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 31, 2013 at 11:30 AM

DGAP-News: MediClin AG: Increase in sales and improvement of results in the 2nd quarter of 2013

DGAP-News: MediClin AG / Key word(s): Half Year Results MediClin AG: Increase in sales and improvement of results in the 2nd quarter of 2013 31.07.2013 / 17:20 --------------------------------------------------------------------- Offenburg, July 31, 2013 - MEDICLIN Aktiengesellschaft (MediClin) has achieved Group sales of EUR 257.4 mill. (1 HY 2012: EUR 254.1 mill.) in the first six months of financial year 2013, thus being EUR 3.3 mill. or 1.3 % above the value of the first half-year of 2012. Sales of the second quarter 2013 amounted to EUR 132.9 mill., which was EUR 4.2 mill. or 3.3 % above previous year's value. The Group operating result of the first half-year of 2013 was EUR -3.6 mill. (1 HY 2012: EUR 1.9 mill.); in the second quarter 2013 a result of EUR 2.3 mill. was achieved (Q2 2012: EUR 2.7 mill.). The two segments post-acute and acute as well as the business area nursing care are reporting sales increase in the half-year and quarterly comparison. In the post-acute segment sales was EUR 147.1 mill. respectively EUR 76.4 mill. (1 HY 2012: EUR 145.5 mill.; Q2 2012: EUR 74.8 mill.). In the acute segment sales accounted for EUR 102.0 mill. respectively EUR 52.4 mill. (1 HY 2012: EUR 100.6 mill.; Q2 2012: EUR 50.0 mill.). The business area nursing care contributed EUR 6.7 mill. respectively EUR 3.4 mill. (1 HY 2012: EUR 6.4 mill.; Q2 2012: EUR 3.2 mill.) to total sales. The half-year and quarterly comparison showed that the results of the post-acute segment of EUR -2.5 mill. respectively EUR 1.7 mill. (1 HY 2013: EUR 1.3 mill.; Q2 2012: EUR 3.0 mill.) were still below the previous years' values. The result of the acute segment was EUR 3.1 mill. (1. HY 2012: EUR 3.9 mill.) for the first half-year of 2013, in which the result of the second quarter of EUR 3.0 mill. (Q2 2012: EUR 1.5 mill.) was significantly above the previous year's value due to a higher occupancy rate. In total the result situation in the segments has improved compared to the first quarter 2013. Especially higher personnel costs burdened the results of the segment, mainly due to a higher number of staff and general wage increases. In the first six months of 2013 about EUR 8.6 mill. (1. HY 2012: EUR 11.2 mill.) were invested in fixed assets (brutto). Another EUR 8.7 mill. (1. HY 2012: EUR 8.1 mill.) were spent for service and maintenance. As of June 30, 2013 cash and cash equivalents amounted to EUR 9.7 mill. (31.12.2012: EUR 22.9 mill.); the equity ratio was 48.5 % (31.12.2012: 49.1 %). MediClin employed on average 6,371 employees, calculated on the basis of full-time staff, in the first half-year of 2013, 193 employees more than on average in the first half-year of 2012. Outlook As regards to the business development of the current financial year, the given outlook is being confirmed. The occupancy at the beginning of the third quarter corresponds to the level of the previous year. The Management Board continues to apply the restructuring measures, started mid-2012, in order to align the clinics to the changing market conditions. MediClin will invest in medical areas, which promise an increase in demand. The interim report as of June 30, 2013 will be available in German and English from August 14, 2013 under www.mediclin.de. About MediClin AG (Ticker: MED; WKN: 659 510) MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 11 Medizinische Versorgungszentren (medical care units) in 11 federal states MediClin has a total capacity of approximately 8,100 beds. MediClins' facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,500 employees. MediClin â?? a company of the Asklepios Group. End of Corporate News --------------------------------------------------------------------- 31.07.2013 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: MediClin AG OkenstraÃ?e 27 77652 Offenburg Germany Phone: +49 (0)781 488-189 Fax: +49 (0)781 488-184 E-mail: alexandra.muehr@mediclin.de Internet: www.mediclin.de ISIN: DE0006595101 WKN: 659510 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, DÃ¼sseldorf, Hamburg, MÃ¼nchen, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 223685 31.07.2013

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

The Real Cost of Cabinet Decisions: Refinish or Replace?

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Govee Stirs Halloween Chills with New Sarah Gellar Ad

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Aetna's 2027 Medicare Plans: Comprehensive Outlook

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Vatrer Power: Lithium Batteries Revolutionize Golf Carts

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Kal Plastics Showcases at Design-2-Part Expo

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Venice's Climate Challenge: Rising Seas, Sinking Lands

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Trading Platforms Poised for Billions by 2031

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Honeywell's Supply Line Snags Bait Class Action Risk

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...